Cubist Systematic Strategies, LLC Mirati Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $253,451 - $376,525	-6,036 Reduced 28.87%	14,869 $873,000
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $581,159 - $948,041	20,905 New	20,905 $910,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $2.08 Million - $3.09 Million	56,929 Added 557.96%	67,132 $2.5 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $102,308 - $244,478	2,479 Added 32.09%	10,203 $462,000
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $864,892 - $1.26 Million	-14,536 Reduced 65.3%	7,724 $539,000
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $138,352 - $313,412	-3,533 Reduced 13.7%	22,260 $1.49 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $1.37 Million - $2.73 Million	18,050 Added 233.11%	25,793 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $894,103 - $1.29 Million	-6,773 Reduced 46.66%	7,743 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $5.07 Million - $6.81 Million	-38,370 Reduced 72.55%	14,516 $2.57 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $5.72 Million - $7.14 Million	39,715 Added 301.53%	52,886 $8.54 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $499,962 - $697,185	3,146 Added 31.38%	13,171 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $506,082 - $750,363	3,123 Added 45.25%	10,025 $2.2 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $395,617 - $584,274	3,493 Added 102.46%	6,902 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $245,482 - $410,409	3,409 New	3,409 $389,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $774,558 - $1.29 Million	-11,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $765,198 - $1.39 Million	10,814 Added 3781.12%	11,100 $1.43 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $1.62 Million - $2.28 Million	-20,781 Reduced 98.64%	286 $22,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $1.25 Million - $2.21 Million	21,067 New	21,067 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $3,200 - $4,743	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $4,710 - $6,270	100 New	100 $5,000
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $164,167 - $330,224	-6,302 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $108,394 - $220,254	6,302 New	6,302 $193,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account